Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...
In older adults with psoriasis or psoriatic arthritis, use of two biologic classes was associated with lowest rates of serious adverse events than time off those drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback